Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Total Non-Current Liabilities (2016 - 2025)

Trinity Biotech's Total Non-Current Liabilities history spans 17 years, with the latest figure at $35.9 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 66.22% to $35.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.9 million, a 66.22% decrease, with the full-year FY2025 number at $35.9 million, down 66.22% from a year prior.
  • Total Non-Current Liabilities hit $35.9 million in Q4 2025 for Trinity Biotech, down from $117.6 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for TRIB hit a ceiling of $117.6 million in Q2 2025 and a floor of $18.7 million in Q4 2021.
  • Historically, Total Non-Current Liabilities has averaged $73.3 million across 5 years, with a median of $77.2 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 82.26% in 2021 and later skyrocketed 310.94% in 2022.
  • Tracing TRIB's Total Non-Current Liabilities over 5 years: stood at $18.7 million in 2021, then surged by 310.94% to $76.9 million in 2022, then fell by 11.17% to $68.3 million in 2023, then skyrocketed by 55.64% to $106.4 million in 2024, then plummeted by 66.22% to $35.9 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for TRIB at $35.9 million in Q4 2025, $117.6 million in Q2 2025, and $106.4 million in Q4 2024.